A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato

Lyme borreliosis (LB) patients who recover, as well as previously infected asymptomatic individuals, remain vulnerable to reinfection with Borrelia burgdorferi sensu lato. There is limited information available about the use of OspA vaccines in this population. In this study, a randomized double-bli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Vaccine Immunol
Main Authors: Wressnigg, Nina, Barrett, P. Noel, Pöllabauer, Eva-Maria, O'Rourke, Maria, Portsmouth, Daniel, Schwendinger, Michael G., Crowe, Brian A., Livey, Ian, Dvorak, Thomas, Schmitt, Bernhard, Zeitlinger, Markus, Kollaritsch, Herwig, Esen, Meral, Kremsner, Peter G., Jelinek, Tomas, Aschoff, Roland, Weisser, Roland, Naudts, Ingomar F. K., Aichinger, Gerald
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4248771/
https://ncbi.nlm.nih.gov/pubmed/25185574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00406-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados